Nyamongo Onkoba
Biographic Data
| ID | 9073868 |
|---|---|
| NAME | Nyamongo Onkoba |
| GIVEN NAMES | Nyamongo |
| FAMILY NAME | Onkoba |
| SIGNATURE | ONKOBA N |
| AFFILIATIONS | Technical University of Kenya |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 3 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Knowledge translation of climate change research into public health action
Background: There are gaps in translating climate change research into public health action at the global level. Knowledge translation refers to the methods used to bridge the gap between knowledge and action. Given the significant impacts of climate change on health, it is essential to integrate climate research into health decision-making processes. This integration ensures that evidence effectively informs policies and practices at all levels,…
Factors associated with Covid-19 vaccine uptake among health professionals in Debre Markos town public health facilities, Northwest Ethiopia
Globally, the COVID-19 pandemic has significantly increased morbidity and mortality. Health professionals are at the frontline of COVID-19 pandemic exposure and are identified as a priority target group that needs to receive COVID-19 vaccines. Data on Ethiopian healthcare workers’ use of the COVID-19 vaccine and associated factors, however, are scarce. Using a simple random sampling method, 398 health professionals were recruited through an insti…
The use of the WHO criteria to detect severe malaria among patients clinically diagnosed with uncomplicated malaria
The World Health Organization (WHO) strict defining criteria were used to identify severe malaria among Ghanaian patients clinically diagnosed as uncomplicated malaria. From each study participant, blood haemoglobin (Hb) and plasma bilirubin levels were estimated using automated analyzers. According to the WHO, the criteria for diagnosing severe malaria among children ( 10,000/μL, plasma bilirubin > 50 μmol/L amidst parasitemia > 100,000/μL and P…
Safety and immunogenicity after a 30-month boost of a subtype C Alvac-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100)
Induction of broad, durable immune responses is a challenge in HIV vaccine development. HVTN 100 Part A administered subtype C-containing ALVAC-HIV at months 0 and 1, and ALVAC-HIV with bivalent subtype C gp120/MF59 at months 3, 6 and 12. As IgG binding antibody and T-cell responses were similar or greater at month 12.5 vs. month 6.5, but waned by month 18, we investigated vaccine-elicited immune responses after a month 30 boost in this study, HV…
No prominent works on this page.
Factors associated with Covid-19 vaccine uptake among health professionals in Debre Markos town public health facilities, Northwest Ethiopia
Globally, the COVID-19 pandemic has significantly increased morbidity and mortality. Health professionals are at the frontline of COVID-19 pandemic exposure and are identified as a priority target group that needs to receive COVID-19 vaccines. Data on Ethiopian healthcare workers’ use of the COVID-19 vaccine and associated factors, however, are scarce. Using a simple random sampling method, 398 health professionals were recruited through an insti…
The use of the WHO criteria to detect severe malaria among patients clinically diagnosed with uncomplicated malaria
The World Health Organization (WHO) strict defining criteria were used to identify severe malaria among Ghanaian patients clinically diagnosed as uncomplicated malaria. From each study participant, blood haemoglobin (Hb) and plasma bilirubin levels were estimated using automated analyzers. According to the WHO, the criteria for diagnosing severe malaria among children ( 10,000/μL, plasma bilirubin > 50 μmol/L amidst parasitemia > 100,000/μL and P…
Safety and immunogenicity after a 30-month boost of a subtype C Alvac-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100)
Induction of broad, durable immune responses is a challenge in HIV vaccine development. HVTN 100 Part A administered subtype C-containing ALVAC-HIV at months 0 and 1, and ALVAC-HIV with bivalent subtype C gp120/MF59 at months 3, 6 and 12. As IgG binding antibody and T-cell responses were similar or greater at month 12.5 vs. month 6.5, but waned by month 18, we investigated vaccine-elicited immune responses after a month 30 boost in this study, HV…
Knowledge translation of climate change research into public health action
Background: There are gaps in translating climate change research into public health action at the global level. Knowledge translation refers to the methods used to bridge the gap between knowledge and action. Given the significant impacts of climate change on health, it is essential to integrate climate research into health decision-making processes. This integration ensures that evidence effectively informs policies and practices at all levels,…
Medicine (3 works) · Immunology (2 works) · Internal Medicine (2 works) · Public health (2 works) · Antibody (1 work) · Antigen (1 work) · Asymptomatic (1 work) · Bilirubin (1 work) · Booster dose (1 work) · Chemistry (1 work)